Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	97.25	186.73	125.74	123.67	117.36
Short-Term Investments	321.66	154.89	111.61	203.24	188.45
Cash & Short-Term Investments	418.91	341.62	237.36	326.9	305.81
Cash Growth	22.63%	43.93%	-27.39%	6.90%	129.90%
Accounts Receivable	165	10	0.01	1.57	2.43
Other Receivables	3.49	0.33	0.04	3.77	1.4
Receivables	168.49	10.33	0.05	5.33	3.82
Prepaid Expenses	4.24	3.63	5.67	8.5	5.97
Restricted Cash	-	-	-	-	0.01
Total Current Assets	591.64	355.58	243.08	340.74	315.61
Property, Plant & Equipment	12.61	2.15	4.63	6.73	6.41
Long-Term Investments	140.25	-	-	-	2
Other Long-Term Assets	0.23	0.23	0.23	0.23	0.45
Total Assets	744.73	357.95	247.93	347.7	324.47
Accounts Payable	1.62	0.77	3.64	1.6	3.08
Accrued Expenses	23.62	19.26	24.54	37.31	18.42
Current Portion of Leases	0.51	1.14	2.52	2.2	1.46
Current Income Taxes Payable	2.69	-	-	-	-
Current Unearned Revenue	18.89	-	-	1.6	14.48
Other Current Liabilities	0.07	0.1	0.48	1.31	2.81
Total Current Liabilities	47.4	21.27	31.18	44.02	40.24
Long-Term Leases	10.36	-	1.14	3.66	4.5
Long-Term Unearned Revenue	11.68	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.12
Total Liabilities	69.43	21.27	32.32	47.67	44.86
Common Stock	0	0	-	-	-
Additional Paid-In Capital	1,016	952.49	752.72	709.68	563.39
Retained Earnings	-340.52	-615.71	-536.76	-409.36	-283.81
Comprehensive Income & Other	-0.08	-0.11	-0.36	-0.3	0.03
Total Common Equity	675.3	336.68	215.61	300.02	279.61
Shareholders' Equity	675.3	336.68	215.61	300.02	279.61
Total Liabilities & Equity	744.73	357.95	247.93	347.7	324.47
Total Debt	10.87	1.14	3.66	5.86	5.96
Net Cash (Debt)	548.3	340.48	233.7	321.04	301.85
Net Cash Growth	61.04%	45.69%	-27.21%	6.36%	160.20%
Net Cash Per Share	8.43	6.00	4.77	6.93	8.78
Filing Date Shares Outstanding	61.38	58.27	51.28	48.41	43.81
Total Common Shares Outstanding	61.04	57.71	49.34	47.84	43.75
Working Capital	544.24	334.3	211.9	296.72	275.37
Book Value Per Share	11.06	5.83	4.37	6.27	6.39
Tangible Book Value	675.3	336.68	215.61	300.02	279.61
Tangible Book Value Per Share	11.06	5.83	4.37	6.27	6.39
Machinery	7.8	6.47	5.91	5.18	4.19
Leasehold Improvements	2.42	0.96	0.91	0.88	0.75

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q